Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Where are the Investors Headed: Complementary Research on Ladder Capital, New York REIT, J.G. Wentworth, Pain Therapeutics and MYOS Corp
Ist Teil von
PR Newswire, 2015
Ort / Verlag
New York: PR Newswire Association LLC
Erscheinungsjahr
2015
Link zum Volltext
Beschreibungen/Notizen
Today's update concerns the following companies: === Full PDF Download Links (you may have to copy and paste the following links into your browser): LADR Research Report: ( http://get.analystsreview.com/pdf/?c=Ladder%20Capital&d=15-May-2015&s=LADR ), NYRT Research Report: ( http://get.analystsreview.com/pdf/?c=New%20York%20REIT&d=15-May-2015&s=NYRT ), JGW Research Report: ( http://get.analystsreview.com/pdf/?c=J.G.%20Wentworth&d=15-May-2015&s=JGW ), PTIE Research Report: ( http://get.analystsreview.com/pdf/?c=Pain%20Therapeutics&d=15-May-2015&s=PTIE ), MYOS Research Report: ( http://get.analystsreview.com/pdf/?c=MYOS%20Corp.&d=15-May-2015&s=MYOS ). === -- Analyst Update: Financial and Operational Results and Clinical Trials U.S. stocks closed higher on Thursday, recovering from a sequence of slight losses over the week. On May 12, 2015, Pain Therapeutics, Inc. announced top-line results of an FDA Category 3 Human Abuse Potential Study with REMOXY Extended-Release Capsules CII, its lead drug candidate that is specifically designed to discourage certain common methods of drug tampering and misuse.